(Q44090402)

29 November 2017

title

UCM707, a potent and selective inhibitor of endocannabinoid uptake, potentiates hypokinetic and antinociceptive effects of anandamide (English)

1 reference

29 November 2017

0 references

0 references

0 references

4

1 reference

29 November 2017

Silvia Ortega-Gutiérrez

object named as

Silvia Ortega-Gutiérrez

3

0 references

Eva de Lago

object named as

Eva de Lago

1

0 references

María L López-Rodríguez

object named as

María Luz López-Rodríguez

5

0 references

author name string

Javier Fernández-Ruiz

2

1 reference

29 November 2017

José A Ramos

6

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 August 2002

1 reference

European Journal of Pharmacology

29 November 2017

published in

1 reference

29 November 2017

volume

449

1 reference

29 November 2017

issue

1-2

1 reference

29 November 2017

page(s)

99-103

1 reference

Functional role of high-affinity anandamide transport, as revealed by selective inhibition

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901996-9

Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901996-9

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901996-9

Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901996-9

Cannabinoid receptors and their endogenous agonists.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901996-9

Nefopam reduces thermal hypersensitivity in acute and postoperative pain models in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901996-9

Elevated circulating levels of anandamide after administration of the transport inhibitor, AM404.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901996-9

Extrapyramidal and neuroendocrine effects of AM404, an inhibitor of the carrier-mediated transport of anandamide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901996-9

Two new unsaturated fatty acid ethanolamides in brain that bind to the cannabinoid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901996-9

Characterization of cannabinoid receptors coupled to vasorelaxation by endothelium-derived hyperpolarizing factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901996-9

Pharmacology of cannabinoid receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901996-9

Regulation of the cAMP cascade, gene expression and immune function by cannabinoid receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901996-9

Head group analogs of arachidonylethanolamide, the endogenous cannabinoid ligand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901996-9

Design, synthesis and biological evaluation of novel arachidonic acid derivatives as highly potent and selective endocannabinoid transporter inhibitors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901996-9

Endocannabinoid Transporter Inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901996-9

Search for endogenous ligands of the cannabinoid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901996-9

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901996-9

Presence and functional regulation of cannabinoid receptors in immune cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901996-9

Pharmacology of cannabinoid CB1 and CB2 receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901996-9

Cannabinoid receptor ligands: clinical and neuropharmacological considerations, relevant to future drug discovery and development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901996-9

The endogenous cannabinoid system and the basal ganglia. biochemical, pharmacological, and therapeutic aspects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901996-9

2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901996-9

Cardiovascular actions of cannabinoids and their generation during shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901996-9

The neurobiology of cannabinoid analgesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901996-9

The anandamide transport inhibitor AM404 activates vanilloid receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901996-9

10.1016/S0014-2999(02)01996-9

7 January 2021

Identifiers

DOI

1 reference

29 November 2017

1 reference